JP2006519815A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519815A5 JP2006519815A5 JP2006504814A JP2006504814A JP2006519815A5 JP 2006519815 A5 JP2006519815 A5 JP 2006519815A5 JP 2006504814 A JP2006504814 A JP 2006504814A JP 2006504814 A JP2006504814 A JP 2006504814A JP 2006519815 A5 JP2006519815 A5 JP 2006519815A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- reaction
- carried out
- alkyl group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-N HF Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- PIJCNSMLEHEOKI-UHFFFAOYSA-N ethyl 2-fluoro-3-oxo-3-pyrimidin-4-ylpropanoate Chemical compound CCOC(=O)C(F)C(=O)C1=CC=NC=N1 PIJCNSMLEHEOKI-UHFFFAOYSA-N 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- -1 4-pyridinyl Chemical group 0.000 claims 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N Trifluoromethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004429 atoms Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- OFJCCPUVEJNLKP-UHFFFAOYSA-N ethyl 2-fluoro-3-oxo-3-pyridin-4-ylpropanoate Chemical compound CCOC(=O)C(F)C(=O)C1=CC=NC=C1 OFJCCPUVEJNLKP-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 239000007789 gas Substances 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 239000012442 inert solvent Substances 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 claims 1
Claims (10)
- 反応が、ギ酸、トリフルオロ酢酸、硫酸、トリフルオロメタンスルホン酸及びフッ化水素酸から選択される1又はそれ以上の酸の存在下で実施される請求項1に記載の方法。
- 反応が溶媒の不在下で実施される請求項1又は2に記載の方法。
- 反応が不活性溶媒たるアセトニトリル又はクロロホルムの存在下で実施される請求項1又は2に記載の方法。
- 反応が、溶媒の不在下にてフッ化水素酸の存在下で実施される請求項2又は3に記載の方法。
- 反応が、化合物(I)(式中、R1は、環が任意にC1〜2アルキル基により置換されていてもよい、3若しくは4−ピリジニル又は4−若しくは5−ピリミジニルを表し、R2は水素原子又はC1〜3アルキル基を表し、R3はC1〜3アルキル基を表す)のために実施される請求項1〜5のいずれか1項に記載の方法。
- 反応が化合物(I):エチル2−フルオロ−3−オキソ−3−ピリジン−4−イルプロパノエート又はエチル2−フルオロ−3−オキソ−3−ピリミジン−4−イルプロパノエートのために実施される請求項1〜6のいずれか1項に記載の方法。
- 請求項1に規定の式(I)の化合物(ただし、化合物(I)はエチル2−フルオロ−3−オキソ−3−ピリジン−4−イルプロパノエートではない)。
- エチル2−フルオロ−3−オキソ−3−ピリミジン−4−イルプロパノエートからなる請求項1に規定の式(I)の化合物。
- R1が、環が任意に置換されていてもよいピリミジン環を表す請求項1に規定の式(I)の化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03290568A EP1454900A1 (en) | 2003-03-07 | 2003-03-07 | Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters |
EP03290568.9 | 2003-03-07 | ||
PCT/EP2004/003052 WO2004078725A1 (en) | 2003-03-07 | 2004-03-05 | Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto esters |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2006519815A JP2006519815A (ja) | 2006-08-31 |
JP2006519815A5 true JP2006519815A5 (ja) | 2007-03-29 |
JP4805809B2 JP4805809B2 (ja) | 2011-11-02 |
Family
ID=32799102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006504814A Expired - Fee Related JP4805809B2 (ja) | 2003-03-07 | 2004-03-05 | ピリジニル及びピリミジニルモノフッ素化βケトエステルの製造方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7135569B2 (ja) |
EP (2) | EP1454900A1 (ja) |
JP (1) | JP4805809B2 (ja) |
CN (1) | CN100398518C (ja) |
AT (1) | ATE353877T1 (ja) |
DE (1) | DE602004004767T2 (ja) |
ES (1) | ES2281786T3 (ja) |
RU (1) | RU2330844C2 (ja) |
WO (1) | WO2004078725A1 (ja) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0996606B1 (en) * | 1997-07-18 | 2002-01-16 | F2 Chemicals Ltd. | Catalysed fluorination of carbonyl compounds |
US6455728B1 (en) * | 1999-11-01 | 2002-09-24 | Air Products And Chemicals, Inc. | Direct fluorination process for preparing high purity 2-fluoro-1,3-dicarbonyl compounds using oxygen as a radical scavenger |
EP1295885A1 (en) * | 2001-09-21 | 2003-03-26 | Sanofi-Synthelabo | Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives |
EP1295884A1 (en) * | 2001-09-21 | 2003-03-26 | Sanofi-Synthelabo | 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives |
DK1674456T3 (da) * | 2001-09-21 | 2008-10-27 | Sanofi Aventis | Nye 1,4-benzothiazepin-1,1-dioxid-derivater med forbedrede egenskaber, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse |
-
2003
- 2003-03-07 EP EP03290568A patent/EP1454900A1/en not_active Withdrawn
-
2004
- 2004-03-05 AT AT04717645T patent/ATE353877T1/de not_active IP Right Cessation
- 2004-03-05 DE DE602004004767T patent/DE602004004767T2/de not_active Expired - Lifetime
- 2004-03-05 RU RU2005131007/04A patent/RU2330844C2/ru not_active IP Right Cessation
- 2004-03-05 ES ES04717645T patent/ES2281786T3/es not_active Expired - Lifetime
- 2004-03-05 WO PCT/EP2004/003052 patent/WO2004078725A1/en active Search and Examination
- 2004-03-05 JP JP2006504814A patent/JP4805809B2/ja not_active Expired - Fee Related
- 2004-03-05 CN CNB200480009687XA patent/CN100398518C/zh not_active Expired - Fee Related
- 2004-03-05 EP EP04717645A patent/EP1603876B1/en not_active Expired - Lifetime
-
2005
- 2005-09-07 US US11/221,023 patent/US7135569B2/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8754230B2 (en) | 4-pyridinone compounds and their use for cancer | |
US10513506B2 (en) | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)pyridin-3-yl and processes of preparation | |
US7541469B2 (en) | Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines | |
EP1947092B1 (en) | Method for producing nucleic acid base having perfluoroalkyl group | |
US8273878B2 (en) | Process for the preparation of pyrimidine compounds | |
JP2009523146A5 (ja) | ||
US8106202B2 (en) | Method for making 1-substituted 1H-imidazo [4,5-C] quinolin-4-amine compounds and intermediates therefor | |
US20180327359A1 (en) | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-oxoethyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
JP2005533804A5 (ja) | ||
US20190382369A1 (en) | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
US20220281861A1 (en) | Process For Preparing Aminopyrimidine Derivatives | |
JP2006519815A5 (ja) | ||
JP2006526587A5 (ja) | ||
US20190284158A1 (en) | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h-1,2,4-triazol-1-yl)propyl)pyridin-3-yl)oxy)benzonitrile and processes of preparation | |
JP2008247919A5 (ja) | ||
EP3292112B1 (en) | Process for the preparation of alogliptin | |
RU2005131007A (ru) | Способ получения монофторированных сложных бета-кетоэфиров пиридинила и пиримидинила | |
US8063226B2 (en) | Process for preparing 2-amino-4-(haloalkyl) pyridine derivatives by cyclizing suitable nitrile precursors with nitrogen compounds | |
JP6372560B2 (ja) | ピラゾール化合物の製造方法 | |
CN1105996A (zh) | 咪唑并吡啶类衍生物的制备方法 | |
JP2000248189A5 (ja) | ||
CN108409672B (zh) | 一种铜盐催化合成多取代嘧啶的方法 | |
Ikemoto et al. | A Practical Synthesis of the Chronic Renal Disease Agent, 4, 5-Dihydro-3H-1, 4, 8b-triazaacenaphthylen-3-one Derivatives, Using Regioselective Chlorination of Ethyl 5-methylimidazo [1, 2-a] pyridine-3-carboxylate with N-Chlorosuccinimide | |
TWI705961B (zh) | 亞托敏的製備方法 | |
US20190276403A1 (en) | T-butyl 2-carbamothioyl-2-(3-(5-(4-cyanophenoxy)pyridin-2-yl)-2-(2,4-difluorophenyl)-3,3-difluoro-2-hydroxypropyl)hydrazine-1-carboxylate and processes of preparation |